搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Koribacter versatilis 30S ribosomal protein S17 (rpsQ) CSB-YP628024KAAA
CSB-EP628024KAAA
CSB-BP628024KAAA
CSB-MP628024KAAA
CSB-EP628024KAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Koribacter versatilis 50S ribosomal protein L2 (rplB) CSB-YP628025KAAA
CSB-EP628025KAAA
CSB-BP628025KAAA
CSB-MP628025KAAA
CSB-EP628025KAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Koribacter versatilis 30S ribosomal protein S10 (rpsJ) CSB-YP628026KAAA
CSB-EP628026KAAA
CSB-BP628026KAAA
CSB-MP628026KAAA
CSB-EP628026KAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Koribacter versatilis 60 kDa chaperonin (groL), partial CSB-YP628027KAAA
CSB-EP628027KAAA
CSB-BP628027KAAA
CSB-MP628027KAAA
CSB-EP628027KAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Koribacter versatilis Kynureninase (kynU) CSB-YP628028KAAA
CSB-EP628028KAAA
CSB-BP628028KAAA
CSB-MP628028KAAA
CSB-EP628028KAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Koribacter versatilis Elongation factor Ts (tsf) CSB-YP628029KAAA
CSB-EP628029KAAA
CSB-BP628029KAAA
CSB-MP628029KAAA
CSB-EP628029KAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Koribacter versatilis Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp) CSB-YP628030KAAA
CSB-EP628030KAAA
CSB-BP628030KAAA
CSB-MP628030KAAA
CSB-EP628030KAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Koribacter versatilis Glutamate--tRNA ligase 2 (gltX2) CSB-YP628031KAAA
CSB-EP628031KAAA
CSB-BP628031KAAA
CSB-MP628031KAAA
CSB-EP628031KAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Koribacter versatilis Glutamate--tRNA ligase 1 (gltX1), partial CSB-YP628032KAAA
CSB-EP628032KAAA
CSB-BP628032KAAA
CSB-MP628032KAAA
CSB-EP628032KAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Deinococcus geothermalis tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (mnmG), partial CSB-YP628033DAAD
CSB-EP628033DAAD
CSB-BP628033DAAD
CSB-MP628033DAAD
CSB-EP628033DAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Deinococcus geothermalis 50S ribosomal protein L21 (rplU) CSB-YP628034DAAD
CSB-EP628034DAAD
CSB-BP628034DAAD
CSB-MP628034DAAD
CSB-EP628034DAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Deinococcus geothermalis ATP-dependent Clp protease ATP-binding subunit ClpX (clpX) CSB-YP628035DAAD
CSB-EP628035DAAD
CSB-BP628035DAAD
CSB-MP628035DAAD
CSB-EP628035DAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Deinococcus geothermalis Carbamoyl-phosphate synthase large chain (carB), partial CSB-YP628036DAAD
CSB-EP628036DAAD
CSB-BP628036DAAD
CSB-MP628036DAAD
CSB-EP628036DAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Deinococcus geothermalis Glycerol-3-phosphate dehydrogenase [NAD (P)+] (gpsA) CSB-YP628037DAAD
CSB-EP628037DAAD
CSB-BP628037DAAD
CSB-MP628037DAAD
CSB-EP628037DAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Deinococcus geothermalis Glycine cleavage system H protein (gcvH) CSB-YP628038DAAD
CSB-EP628038DAAD
CSB-BP628038DAAD
CSB-MP628038DAAD
CSB-EP628038DAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Deinococcus geothermalis Elongation factor Tu (tuf1) CSB-YP628039DAAD
CSB-EP628039DAAD
CSB-BP628039DAAD
CSB-MP628039DAAD
CSB-EP628039DAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Deinococcus geothermalis 50S ribosomal protein L22 (rplV) CSB-YP628040DAAD
CSB-EP628040DAAD
CSB-BP628040DAAD
CSB-MP628040DAAD
CSB-EP628040DAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Deinococcus geothermalis 30S ribosomal protein S8 (rpsH) CSB-YP628041DAAD
CSB-EP628041DAAD
CSB-BP628041DAAD
CSB-MP628041DAAD
CSB-EP628041DAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Deinococcus geothermalis Type III pantothenate kinase (coaX) CSB-YP628042DAAD
CSB-EP628042DAAD
CSB-BP628042DAAD
CSB-MP628042DAAD
CSB-EP628042DAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Deinococcus geothermalis Ribosomal RNA large subunit methyltransferase H (rlmH) CSB-YP628043DAAD
CSB-EP628043DAAD
CSB-BP628043DAAD
CSB-MP628043DAAD
CSB-EP628043DAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>